3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Skin Neoplasms
2
Myelodysplastic Syndromes
2
Prostatic Neoplasms
1
Neoplasms
1
Myofibroma
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Intraocular Lymphoma
1
Inflammation
1
Hemorrhage
1
Eye Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cytopenia
1
Corneal Endothelial Cell Loss
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Cataract
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenomyosis
1
Interventions
Cytarabine
19
Cyclophosphamide
18
venetoclax
15
fludarabine phosphate
14
Busulfan
14
Cyclosporine
12
Azacitidine
11
fludarabine
10
Peripheral Blood Stem Cell Transplantation
10
Granulocyte Colony-Stimulating Factor
10
Mycophenolic Acid
9
Filgrastim
9
Melphalan
8
Antilymphocyte Serum
8
Whole-Body Irradiation
7
Palliative Care
7
Idarubicin
6
Blood Specimen Collection
6
Methotrexate
5
Therapeutics
4
Specimen Handling
4
Radiotherapy
4
Methods
4
Early Intervention, Educational
4
Daunorubicin
4
Cord Blood Stem Cell Transplantation
4
thymoglobulin
3
Thiotepa
3
Tacrolimus
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myeloid, Acute
×
Ascorbic Acid
×
Clear all
NCT02877277
2018-09-24
EVITA-Pilot
Rigshospitalet, Denmark
Phase NA
Completed
20 enrolled